Marrone Bio Innovations, Inc. – NASDAQ:MBII

Add to watchlist

$0.798

Market closed

Open in 3 days

-17.52%

month

-12.38%

quarter

-45.34%

year

Market Cap	N/A
Enterprise value	171.55M

P/E	-6.82
EV/Sales	3.86
EV/EBITDA	-11.83
Price/Sales	3.27
Price/Book	6.35
PEG ratio	N/A
EPS	-0.11

Revenue	44.36M
EBITDA	-14.49M
Income	-20.88M
Revenue Q/Q	0.53%
Revenue Y/Y	38.03%

Profit margin	-47.08%
Oper. margin	-43.72%
Gross margin	59.69%
EBIT margin	-43.72%
EBITDA margin	-32.67%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Marrone Bio Innovations, Inc. (NASDAQ:MBII): Profit margin
Jun 2021	12.59M	-3.03M	-24.09%
Sep 2021	9.85M	-4.94M	-50.17%
Dec 2021	10.81M	-5.31M	-49.11%
Mar 2022	11.09M	-7.59M	-68.45%

Marrone Bio Innovations, Inc. (NASDAQ:MBII): Earnings per share (EPS)
2021-11-10	-0.03	-0.03
2022-03-28	-0.03	-0.03
2022-05-11	-0.02	-0.04

Marrone Bio Innovations, Inc. (NASDAQ:MBII): Debt to assets
Jun 2021	85618000	50.93M	59.49%
Sep 2021	82138000	51.51M	62.71%
Dec 2021	87056000	57.40M	65.94%
Mar 2022	76214000	53.34M	69.99%

Marrone Bio Innovations, Inc. (NASDAQ:MBII): Cash Flow
Jun 2021	-1.24M	-425K	213K
Sep 2021	-308K	-361K	-1.75M
Dec 2021	-3.39M	-188K	8.15M
Mar 2022	-8.39M	-198K	-1.66M

Marrone Bio Innovations alternative data

Social Media

🎓 Academy: How impactful can social media data be in investment decisions

Marrone Bio Innovations
Employees

Marrone Bio Innovations, Inc. (NASDAQ:MBII): Employee count
Aug 2023	153
Sep 2023	153
Oct 2023	153
Nov 2023	153
Dec 2023	153
Jan 2024	153
Feb 2024	153
Mar 2024	153
Apr 2024	153
May 2024	153
Jun 2024	153
Jul 2024	153

Marrone Bio Innovations
Insider Trading

Marrone Bio Innovations, Inc. (NASDAQ:MBII): Insider trades (number of shares)
Period	Buy	Sel
Jul 2021	0	34865
Aug 2021	0	42368
Mar 2022	0	22728
May 2022	0	21009
Jun 2022	0	20492

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Option	12 Jul 2022	PITTS KEITH officer: SVP & Chief Sust. Officer officer: SVP & Chief Sust. Offi..	Restricted Stock Units	102,950	N/A	N/A
Option	12 Jul 2022	MOORE LINDA V officer: Chief Legal Officer officer: Chief Legal Officer	Restricted Stock Units	316,153	N/A	N/A
Option	12 Jul 2022	MAGO YOGESH director director	Restricted Stock Units	321,770	N/A	N/A
Option	12 Jul 2022	MARRONE PAMELA G director	Restricted Stock Units	195,007	N/A	N/A
Option	12 Jul 2022	WOODS ROBERT A director director	Restricted Stock Units	455,027	N/A	N/A
Option	12 Jul 2022	LEE LARA L director director	Restricted Stock Units	167,812	N/A	N/A
Option	12 Jul 2022	VASAVADA AMIT officer: SVP & CTO officer: SVP & CTO	Restricted Stock Units	129,184	N/A	N/A
Option	12 Jul 2022	JOHNSON TIMOTHY B officer: VP (Field and Technical) officer: VP (Field and Technical)	Restricted Stock Units	102,167	N/A	N/A
Option	12 Jul 2022	MCGOVERN KEITH director director	Restricted Stock Units	273,643	N/A	N/A
Option	12 Jul 2022	WOCHOK ZACHARY S. director director	Restricted Stock Units	429,081	N/A	N/A

MBII insider trading transactions

Marrone Bio Innovations
Patents

Status	Patent	Filling date	Issue date
Application	Application MICROBES, COMPOSITIONS, AND USES FOR INCREASING PLANT YIELD AND/OR DROUGHT TOLERANCE Filling date: 12 Mar 2020 Issue date: 11 Aug 2022	12 Mar 2020	11 Aug 2022
Grant	Grant Utility: Bacillus megaterium bioactive compositions and metabolites Filling date: 30 Mar 2020 Issue date: 12 Jul 2022	30 Mar 2020	12 Jul 2022
Grant	Grant Utility: Isolated bacterial strain of the genus Burkholderia and pesticidal metabolites therefrom Filling date: 24 Jun 2019 Issue date: 12 Jul 2022	24 Jun 2019	12 Jul 2022
Application	Application METHODS AND COMPOSITIONS THAT INCREASE PESTICIDAL ACTIVITY FOR FR901228 Filling date: 23 Nov 2021 Issue date: 16 Jun 2022	23 Nov 2021	16 Jun 2022
Application	Application HERBICIDAL COMPOUND Filling date: 22 Nov 2021 Issue date: 17 Mar 2022	22 Nov 2021	17 Mar 2022
Application	Application A METHOD FOR INCREASING ROMIDEPSIN PRODUCTION FROM FERMENTATION BROTH Filling date: 29 Oct 2019 Issue date: 17 Feb 2022	29 Oct 2019	17 Feb 2022
Application	Application Use of Burkholderia Formulations, Compositions and Compounds to Modulate Crop Yield and/or Corn Rootworm Infestation Filling date: 12 Oct 2021 Issue date: 27 Jan 2022	12 Oct 2021	27 Jan 2022
Grant	Grant Utility: Herbicidal compound Filling date: 6 Sep 2018 Issue date: 28 Dec 2021	6 Sep 2018	28 Dec 2021
Application	Application Chromobacterium Subtsugae Genes Filling date: 23 Aug 2021 Issue date: 23 Dec 2021	23 Aug 2021	23 Dec 2021
Application	Application Chromobacterium Subtsugae Genome Filling date: 23 Aug 2021 Issue date: 16 Dec 2021	23 Aug 2021	16 Dec 2021

MBII patents

Marrone Bio Innovations
Earnings Call Transcripts

Quarter	Transcript
Q1 2022 11 May 2022	Q1 2022 Earnings Call Transcript
Q4 2021 28 Mar 2022	Q4 2021 Earnings Call Transcript
Q3 2021 10 Nov 2021	Q3 2021 Earnings Call Transcript
Q2 2021 16 Aug 2021	Q2 2021 Earnings Call Transcript

MBII earnings call transcripts

Marrone Bio Innovations
Executives

Insider	Age	Since	Compensation
Mr. Kevin R. Helash (1965) Chief Executive Officer & Director	60		$418,620
Dr. Pamela G. Marrone Ph.D. (1957) Founder, Advisor & Non-Employee Director	68		$408,630

Marrone Bio Innovations
Latest News

Tuesday, 12 July 2022
16:43	Bioceres Crop Solutions Completes Merger With Marrone Bio, Creating a Global Leader in Sustainable Agricultural Solutions	businesswire.com
Monday, 11 July 2022
08:30	Marrone Bio Innovations, Inc. Shareholders Approve Merger Agreement with Bioceres Crop Solutions Corp.	globenewswire.com
Tuesday, 17 May 2022
14:18	Marrone Bio's (MBII) Earnings and Revenues Miss Estimates in Q1	Zacks Investment Research
Wednesday, 11 May 2022
20:01	Marrone Bio Innovations, Inc. (MBII) CEO Kevin Helash on Q1 2022 Results - Earnings Call Transcript	Seeking Alpha
18:49	Marrone Bio Innovations, Inc. (MBII) Reports Q1 Loss, Lags Revenue Estimates	Zacks Investment Research
Monday, 28 March 2022
21:49	Marrone Bio Innovations, Inc. (MBII) Reports Q4 Loss, Tops Revenue Estimates	Zacks Investment Research
19:48	Marrone Bio Innovations, Inc. (MBII) CEO Kevin Helash on Q4 2021 Results - Earnings Call Transcript	Seeking Alpha
Tuesday, 22 March 2022
10:22	Best Penny Stocks To Buy? 4 Agriculture & Farmings Stocks To Watch	PennyStocks
Thursday, 17 March 2022
14:33	Why Is Marrone Bio Innovations (MBII) Stock Up Today?	InvestorPlace
Tuesday, 8 March 2022
08:00	Marrone Bio Innovations to Report Fourth Quarter and Full Year 2021 Results on Monday, March 28 at 4:30 p.m. Eastern Time	GlobeNewsWire
Monday, 10 January 2022
11:30	Marrone (MBII) Expands the Existing Inventory Line of Credit	Zacks Investment Research
Thursday, 25 November 2021
05:51	Switching From Israel Chemicals To Mosaic	Seeking Alpha
Tuesday, 16 November 2021
14:30	7 Penny Stocks to Book Profits on Before 2022	InvestorPlace
Monday, 15 November 2021
09:15	Marrone Bio (MBII) Q3 Earnings In Line, Revenues Lag Estimates	Zacks Investment Research
Wednesday, 10 November 2021
23:00	Marrone Bio Innovations' (MBII) CEO Kevin Helash on Q3 2021 Results - Earnings Call Transcript	Seeking Alpha
19:05	Marrone Bio Innovations, Inc. (MBII) Reports Q3 Loss, Misses Revenue Estimates	Zacks Investment Research
Thursday, 9 September 2021
08:00	Marrone Bio Prepares to Submit Registration for Next-Generation Crop Protection Product in North America	GlobeNewsWire
Thursday, 19 August 2021
09:59	Marrone (MBII) & Terramera Partner to Boost Crop Protection	Zacks Investment Research
Wednesday, 18 August 2021
07:40	Marrone Bio (MBII) Q2 Earnings and Revenues Miss Estimates	Zacks Investment Research
Monday, 16 August 2021
21:55	Marrone Bio Innovations' (MBII) CEO Kevin Helash on Q2 2021 Results - Earnings Call Transcript	Seeking Alpha
19:03	Marrone Bio Innovations, Inc. (MBII) Reports Q2 Loss, Lags Revenue Estimates	Zacks Investment Research
17:19	Marrone Bio Innovations: Q2 Earnings Insights	Benzinga
16:01	Marrone Bio Innovations, Inc. Reports Second-Quarter 2021 Financial Results	GlobeNewsWire

Ideas & Opinions

Seeking Alpha 23 May 2022

Merger Arbitrage Mondays: Carlyle To Acquire Defense Contractor ManTech
Seeking Alpha 25 Nov 2021

Switching From Israel Chemicals To Mosaic

Frequently Asked Questions (FAQ)

What's the price of Marrone Bio Innovations stock today?

One share of Marrone Bio Innovations stock can currently be purchased for approximately $0.8.
When is Marrone Bio Innovations's next earnings date?

Unfortunately, Marrone Bio Innovations's (MBII) next earnings date is currently unknown.
Does Marrone Bio Innovations pay dividends?

No, Marrone Bio Innovations does not pay dividends.
What is Marrone Bio Innovations's stock symbol?

Marrone Bio Innovations, Inc. is traded on the NASDAQ under the ticker symbol "MBII".
What is Marrone Bio Innovations's primary industry?

Company operates in the Basic Materials sector and Agricultural Inputs industry.
How do i buy shares of Marrone Bio Innovations?

Shares of Marrone Bio Innovations can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are Marrone Bio Innovations's key executives?
Marrone Bio Innovations's management team includes the following people:
- Mr. Kevin R. Helash Chief Executive Officer & Director(age: 60, pay: $418,620)
- Dr. Pamela G. Marrone Ph.D. Founder, Advisor & Non-Employee Director(age: 68, pay: $408,630)
Is Marrone Bio Innovations founder-led company?

Yes, Marrone Bio Innovations is a company led by its founder Dr. Pamela G. Marrone Ph.D..
How many employees does Marrone Bio Innovations have?

As Jul 2024, Marrone Bio Innovations employs 153 workers.
When Marrone Bio Innovations went public?

Marrone Bio Innovations, Inc. is publicly traded company for more then 12 years since IPO on 2 Aug 2013.
What is Marrone Bio Innovations's official website?

The official website for Marrone Bio Innovations is marronebio.com.
Where are Marrone Bio Innovations's headquarters?

Marrone Bio Innovations is headquartered at 1540 Drew Ave, Davis, CALIFORNIA.
How can i contact Marrone Bio Innovations?

Marrone Bio Innovations's mailing address is 1540 Drew Ave, Davis, CALIFORNIA and company can be reached via phone at +1 530 750 2800.

Marrone Bio Innovations, Inc.

marronebio.com

Exchange:

NASDAQ

Full time employees:

153

Industry:

Agricultural Inputs

Sector:

Basic Materials

Marrone Bio Innovations, Inc. discovers, develops, and sells biological products for crop protection, crop health, and crop nutrition. Its products include Emergen, Foramin, Foramin ST, Optima, Takla, Pacesetter, Ympact, UBP, and UBP ST for increasing crop health, yield, and quality; Grandevo, a bioinsecticide that controls sucking and chewing insects through feeding; Haven, a plant health product to reduce sun stress and dehydration; Jet-Ag and Jet-Oxide peroxyacetic acid sanitizers that prevent, suppress, eliminate, and control algae, fungi, and bacterial diseases in agriculture and horticultural industries; and Majestene, a bionematicide to control soil-dwelling nematodes and certain soil borne insects. The company also offers Regalia and Stargus, which protects against fungal and bacterial diseases and enhances yields/quality; Venerate, a bioinsecticide that controls chewing and sucking insects and mites; and Zelto, a bionematicide that protects turf, including golf course fairways and greens, and promotes turf health by enhancing plant and root health. It provides its products directly through sales force, as well as through distributors and other commercial partners. The company formerly known as Marrone Organic Innovations, Inc. Marrone Bio Innovations, Inc. was incorporated in 2006 and is headquartered in Raleigh, North Carolina.

+1 530 750 2800

1540 Drew Ave
Davis, CALIFORNIA 27617

CIK: 0001441693
ISIN: US57165B1061
CUSIP: 57165B106